Paul Moayyedi, MB, ChB, BSc, PhD, MPH
SPECIALTY AND TITLE
Hamilton Health Sciences
AREA OF RESEARCH
I am a proponent of evidence based medicine and have conducted large observational studies as well as randomized controlled trials evaluating Helicobacter pylori population screening, inflammatory bowel disease, functional GI disease and gastro-esophageal reflux disease.
MAJOR CONTRIBUTIONS TO SCIENCE AND/OR HEALTH CARE DELIVER
We were the first to show that fecal microbiota transplant may be effective in active ulcerative colitis in a randomized trial. We were also the first to show that aspirin and acid suppression can prevent neoplastic progression in Barrett’s esophagus.